Korean pharmas’ intensified reliability only on developing generic medicines
When it comes to the generic drug development, Korean pharmaceutical companies were analyzed to focus only on medicines with expired patents. This year, there were 625 medicines recognized by bioequivalent test, which the number was decreased by more than 50% compared to the last year.
Moreover,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
